Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents

NCT01073111 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Atherosclerosis

Interventions

DEVICE: zotarolimus-eluting stent (ENDEAVOR®)
DEVICE: sirolimus-eluting stents (CYPHER SELECT® PLUS)
DEVICE: everolimus-eluting stents (PROMUS®)

Sponsor

Hyogo Medical University